Wang, Qiuke
Runhaar, Jos
Kloppenburg, Margreet
Boers, Maarten
Bijlsma, Johannes W. J.
Bierma-Zeinstra, Sita M. A.
Aerts-Lankhorst, N. E.
Agricola, R.
Bastick, A. N.
van Bentveld, R. D. W.
van den Berg, P. J.
Bijsterbosch, J.
de Boer, A.
Boers, M.
Bohnen, A. M.
Boonen, A. E. R. C. H.
Bos, P. K.
Boymans, T. A. E. J.
Breedveldt-Boer, H. P.
Brouwer, R. W.
Colaris, J. W.
Damen, J.
Elshout, G.
Emans, P. J.
Enthoven, W. T. M.
Frölke, E. J. M.
Glijsteen, R.
van der Heide, H. J. C.
Huisman, A. M.
van Ingen, R. D.
Jacobs, M. L.
Janssen, R. P. A.
Kevenaar, P. M.
van Koningsbrugge, M. A.
Krastman, P.
Kuchuk, N. O.
Landsmeer, M. L. A.
Lems, W. F.
van der Linden, H. M. J.
van Linschoten, R.
Mahler, E. A. M.
van Meer, B. L.
Meuffels, D. E.
der Laan, W. H. Noort-van
van Ochten, J. M.
van Oldenrijk, J.
Pols, G. H. J.
Piscaer, T. M.
Rijkels-Otters, J. B. M.
Riyazi, N.
Schellingerhout, J. M.
Schers, H. J.
Schouten, B. W. V.
Snijders, G. F.
van Spil, W. E.
Stitzinger, S. A. G.
Tolk, J. J.
van Trier, Y. D. M.
Vis, M.
Voorbrood, V. M. I.
de Vos, B. C.
de Vries, A.
,
Funding for this research was provided by:
Dutch Arthritis Society (15-1-301)
China Scholarship Council (201906230308)
Article History
Received: 17 March 2021
Accepted: 3 August 2021
First Online: 19 August 2021
Declarations
:
: The protocol has been approved by the Ethical Committee of UMC Utrecht (protocol number 02/017-E). Informed consent was obtained from all participants before the enrollment of the CHECK cohort.
: Not applicable.
: J.R reports grants from Dutch Arthritis Society, during the conduct of the study; M.K reports grants from Dutch Arthritis Association, during the conduct of the study; other from Fee for consultancy (Abbvie, Pfizer, Levicept, GlaxoSmithKline, Merck-Serono, Kiniksa, Flexion, Galapagos, CHDR) and local investigator of industry-driven trial (Abbvie), from Wolters Kluwer (UptoDate), Springer Verlag (Reumatologie en klinische immunologie), grants from Pfizer, grants from IMI-APPROACH, outside the submitted work; SB-Z reports grants from European union, Foreum, The Netherlands Organisation for Health Research and Development, Dutch Arthritis Association, CZ, personal fees from OARSI, personal fees from Pfizer, outside the submitted work.